Morgan Stanley Dr Reddys Laboratories LTD Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Morgan Stanley holds 2,242,132 shares of RDY stock, worth $31.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,242,132

Previous 2,030,028 10.45%

Holding current value

$31.8 Million

Previous $155 Million 15.17%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$75.41 - $84.21 $16 Million - $17.9 Million	212,104 Added 10.45%	2,242,132 $178 Million
Q2 2024 Oct 17, 2024	BUY	$68.26 - $76.19 $78.7 Million - $87.9 Million	1,153,139 Added 131.5%	2,030,028 $155 Million
Q2 2024 Aug 14, 2024	BUY	$68.26 - $76.19 $78.7 Million - $87.9 Million	1,153,139 Added 131.5%	2,030,028 $155 Million
Q1 2024 Oct 17, 2024	SELL	$67.36 - $77.59 $77.7 Million - $89.5 Million	-1,153,139 Reduced 56.8%	876,889 $64.3 Million
Q1 2024 Aug 16, 2024	BUY	$67.36 - $77.59 $3.93 Million - $4.53 Million	58,337 Added 7.13%	876,889 $64.3 Million
Q1 2024 May 15, 2024	BUY	$67.36 - $77.59 $3.93 Million - $4.53 Million	58,337 Added 7.13%	876,889 $64.3 Million
Q4 2023 Aug 16, 2024	SELL	$64.27 - $69.9 $77.9 Million - $84.7 Million	-1,211,476 Reduced 59.68%	818,552 $57 Million
Q4 2023 Feb 13, 2024	BUY	$64.27 - $69.9 $5.25 Million - $5.71 Million	81,752 Added 11.1%	818,552 $57 Million
Q3 2023 Nov 15, 2023	BUY	$61.9 - $72.77 $5.4 Million - $6.35 Million	87,274 Added 13.44%	736,800 $49.3 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $2.4 Million - $2.84 Million	44,927 Added 7.43%	649,526 $41 Million
Q1 2023 May 15, 2023	BUY	$51.63 - $56.93 $1.43 Million - $1.58 Million	27,776 Added 4.82%	604,599 $34.4 Million
Q4 2022 Feb 14, 2023	SELL	$51.15 - $57.45 $26 Million - $29.2 Million	-508,167 Reduced 46.84%	576,823 $29.9 Million
Q3 2022 Nov 14, 2022	BUY	$49.9 - $57.32 $4.25 Million - $4.89 Million	85,226 Added 8.52%	1,084,990 $56.8 Million
Q2 2022 Oct 27, 2022	BUY	$49.62 - $58.13 $25.1 Million - $29.4 Million	504,935 Added 102.04%	999,764 $55.4 Million
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $25.1 Million - $29.4 Million	504,935 Added 102.04%	999,764 $55.4 Million
Q1 2022 Oct 27, 2022	SELL	$48.27 - $65.25 $24.4 Million - $32.9 Million	-504,935 Reduced 50.51%	494,829 $27.6 Million
Q1 2022 May 13, 2022	BUY	$48.27 - $65.25 $12.3 Million - $16.6 Million	254,131 Added 105.58%	494,829 $27.6 Million
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $15.1 Million - $17.1 Million	-253,731 Reduced 51.32%	240,698 $15.7 Million
Q3 2021 Nov 15, 2021	BUY	$60.19 - $75.29 $29.8 Million - $37.2 Million	494,429 New	494,429 $32.2 Million

Others Institutions Holding RDY

# of Institutions

244

Shares Held

23.2M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.36B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account